Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

Many small molecules and monoclonal antibodies blocking the activity of Epidermal Growth factor receptor (EGFR) have been developed and have shown clinical activity in patients with non-small cell lung cancer (NSCLC), pancreatic cancer, and colorectal cancer (CRC), and are in clinical development fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Giovannini, Monica, Gregorc, Vanesa, Belli, Carmen, Roca, Elisa, Lazzari, Chiara, Viganò, Maria Grazia, Serafico, Anna, Villa, Eugenio
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699661/
https://www.ncbi.nlm.nih.gov/pubmed/19584908
http://dx.doi.org/10.1155/2009/849051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699661/
https://www.ncbi.nlm.nih.gov/pubmed/19584908
http://dx.doi.org/10.1155/2009/849051

Ejemplares similares